In part two of a two-part interview (read part one here), Mikel Arriola of the IMSS discusses the strategic roadmap IMSS will follow under his tenure with regards to innovation access and chronic disease prevention, as well as his approach to the upcoming implementation of exchanges of services among the different social security institutions in Mexico.
Mexico is now in the midst of an epidemiological and demographic transition that is placing evermore stress on the IMSS budget. Chronic, degenerative disease is now estimated to cost the Mexican state around 80 billion pesos per annum [USD 4.3 billion]. To what extent can a refocusing on ‘preventative healthcare’ alleviate these pressures?
IMSS will be the first institution to develop and build an effective prevention-based strategic program integrated at the family care level.
